Literature DB >> 18008218

Human papillomavirus vaccine should be given before sexual debut for maximum benefit.

Allan Hildesheim, Rolando Herrero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18008218     DOI： 10.1086/522869

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  14 in total

1.  Acceptability of HPV vaccine among a national sample of gay and bisexual men.

Authors:  Paul L Reiter; Noel T Brewer; Annie-Laurie McRee; Paul Gilbert; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2010-03       Impact factor: 2.830

2.  Knowledge, perceptions, and motivations related to HPV vaccination among college women.

Authors:  Megan K Bendik; Rachel M Mayo; Veronica G Parker
Journal:  J Cancer Educ       Date:  2011-09       Impact factor: 2.037

Review 3.  Perspective for prophylaxis and treatment of cervical cancer: an immunological approach.

Authors:  Marjorie Jenkins; Maurizio Chiriva-Internati; Leonardo Mirandola; Catherine Tonroy; Sean S Tedjarati; Nicole Davis; Nicholas D'Cunha; Lukman Tijani; Fred Hardwick; Diane Nguyen; W Martin Kast; Everardo Cobos
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

4.  Statewide HPV vaccine initiation among adolescent females in North Carolina.

Authors:  Paul L Reiter; Joan R Cates; Annie-Laurie McRee; Sami L Gottlieb; Autumn Shafer; Jennifer S Smith; Noel T Brewer
Journal:  Sex Transm Dis       Date:  2010-09       Impact factor: 2.830

5.  Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men.

Authors:  Paul L Reiter; Noel T Brewer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2009-11-30       Impact factor: 3.519

6.  HPV knowledge and vaccine acceptability among Hispanic fathers.

Authors:  Julie Kornfeld; Margaret M Byrne; Robin Vanderpool; Sarah Shin; Erin Kobetz
Journal:  J Prim Prev       Date:  2013-04

7.  Trends in HPV vaccine initiation among adolescent females in North Carolina, 2008-2010.

Authors:  Jennifer L Moss; Melissa B Gilkey; Paul L Reiter; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-09-20       Impact factor: 4.254

8.  Vaccination against human papillomavirus in Switzerland: simulation of the impact on infection rates.

Authors:  André Berchtold; Pierre-André Michaud; Denise Nardelli-Haefliger; Joan-Carles Surís
Journal:  Int J Public Health       Date:  2009-10-01       Impact factor: 3.380

9.  Immunological characterization of a modified vaccinia virus Ankara vector expressing the human papillomavirus 16 E1 protein.

Authors:  Christelle Remy-Ziller; Claire Germain; Anita Spindler; Chantal Hoffmann; Nathalie Silvestre; Ronald Rooke; Jean-Yves Bonnefoy; Xavier Préville
Journal:  Clin Vaccine Immunol       Date:  2013-12-04

Review 10.  Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women.

Authors:  V Tsu; M Murray; S Franceschi
Journal:  Br J Cancer       Date:  2012-09-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.